Home/Healthcare/Rare Diseases/Myopia And Presbyopia Treatment Market

Myopia And Presbyopia Treatment Market - Strategic Insights and Forecasts (2026-2031)

Market Analysis, Forecasts and Opportunities By Disease Type (Myopia, Presbyopia), By Treatment Type (Prescription Lenses, Contact Lenses, Surgery, Medication), By End User (Hospitals, Eyecare Centers & Clinics, Others), and Geography

$3,950
Single User License
Report OverviewSegmentationTable of ContentsCustomize Report

Request Customization

Tell us your specific requirements and we will customize this report for you.

📞

Your data is secure. We do not share information with any third party.

Myopia And Presbyopia Treatment Market Report

Report IDKSI061615898
PublishedJan 2026
Pages143
FormatPDF, Excel, PPT, Dashboard

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Frequently Asked Questions

The Myopia and Presbyopia Treatment Market is forecasted to exhibit robust growth, rising at an 8.47% CAGR. This strong trajectory will lead to the market expanding from USD 28.434 billion in 2025 to an estimated USD 46.307 billion by 2031, as detailed in the report.

Key growth drivers include the rising global prevalence of both myopia (nearsightedness) and presbyopia (age-related farsightedness), along with a rapidly increasing aging population worldwide. Additionally, technological advancements in ophthalmic diagnostics and refractive surgeries, coupled with changing lifestyles and greater treatment awareness, are bolstering market growth.

North America is projected to maintain a significant market share due to several contributing factors. These include the high prevalence of refractive disorders in the region, a well-established advanced healthcare infrastructure, a rising elderly population, and the strong presence of leading ophthalmic technology providers.

The escalating global prevalence of myopia is a significant growth driver, with the Myopia Focus Organization estimating 2.6 billion people currently affected and projecting over 50% of the population to have myopia by 2050. This dramatic increase ensures sustained and growing demand for myopia treatment solutions, playing a crucial role in driving overall market expansion.

The global aging population is a major accelerator for the presbyopia treatment market, as presbyopia is an age-related condition more common in older adults. With the WHO projecting the population aged 60 years or above to increase from 1 billion in 2020 to 1.4 billion in 2030, there will be a significantly higher demand for corrective methods such as reading glasses, contact lenses, and surgical procedures.

The report highlights significant technological advancements in ophthalmic diagnostics and refractive surgeries, which are improving treatment precision and expanding patient adoption. These innovations include procedures like LASIK, PRK, and SMILE, alongside advanced diagnostic tools such as OCT imaging and wavefront-guided therapies, all contributing to more effective vision correction solutions.

Need data specifically for your business?Request Custom Research →
Related Reports

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon